Related Experiment Videos
Electrocardiographic monitoring: temporal versus spatial information and data processing
Insights
Long-term electrocardiographic recording, or Holter monitoring, aids in diagnosing ischemic heart disease by correlating symptoms with cardiac events. Despite limitations, it remains crucial for evaluating treatment effectiveness and disease progression.
Area of Science:
- Cardiology
- Medical Diagnostics
Background:
- Ischemic heart disease diagnosis relies on electrocardiographic monitoring.
- Long-term electrocardiographic recording offers advantages over standard methods.
Purpose of the Study:
- To evaluate the role and limitations of Holter monitoring in diagnosing ischemic heart disease.
- To assess its utility in patient screening, treatment evaluation, and disease progression monitoring.
Main Methods:
- Utilized long-term electrocardiographic recording (Holter monitoring).
- Compared Holter monitoring with visual electrocardiographic monitoring in Coronary Care Units.
- Analyzed the effectiveness of Holter monitoring in ambulatory patients and during acute/chronic treatment phases.
Main Results:
- Holter monitoring effectively relates symptoms to cardiac disturbances and detects asymptomatic events.
- It reveals electrocardiographic alterations during ischemic attacks and aids in diagnosing dysrhythmias.
- Its sensitivity in Coronary Care Units surpasses visual monitoring, and it's vital for assessing treatment efficacy.
Conclusions:
- Holter monitoring is essential for ambulatory screening and characterizing patients with suspected or ascertained myocardial ischemia.
- Despite limitations in current systems (e.g., single-lead analysis, insufficient duration, lack of standardized analysis), its role in disease evaluation is significant.
- Further research and technical advancements are needed to enhance reliability and data processing for improved diagnostic accuracy.
Abstract:
In the diagnosis of ischemic heart disease, long-term electrocardiographic recording has several distinct advantages. It allows one to relate patient symptoms to cardiac disturbances and to detect asymptomatic events, furnishes the whole spectrum of electrocardiographic alterations accompanying ischemic attacks, reveals the possible ischemic genesis of dysrhythmias, and is the most suitable method to assess the acute and chronic effectiveness of treatment and the evolution of the disease. In addition to its valuable application in the screening and follow-up of ambulatory patients, its use in the Coronary Care Unit is of great interest, being in this context much more sensitive than visual electrocardiographic monitoring. In spite of these advantages, Holter monitoring has several limitations: the recording and replay systems are below recommended standards; the analysis of a single lead is responsible in most systems for the low sensitivity in detecting ischemia occurring in unexplored regions; the period of 24-48 hours, usually adopted for Holter monitoring, may not be sufficient for screening patients with suspected myocardial ischemia due to the unpredictable spontaneous variability of the disease; a common standard of analysis is still lacking and a reliable computerized analysis is needed to manage data overflow. In conclusion, although further research and technical developments are desired to improve reliability and data processing, the role of Holter monitoring appears essential in the ambulatory screening of patients with suspected ischemia for a better characterization of patients with ascertained myocardial ischemia, and for the evaluation of treatment and of the evolution of the disease.